Follow
Jonathan Williams, MD, MMSc
Jonathan Williams, MD, MMSc
Associate Professor of Medicine Harvard Medical School / Brigham and Women's Hospital
Verified email at partners.org
Title
Cited by
Cited by
Year
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ...
The Lancet 391 (10137), 2335-2345, 2018
6592018
Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans
JP Forman, JS Williams, NDL Fisher
Hypertension 55 (5), 1283-1288, 2010
4602010
The unrecognized prevalence of primary aldosteronism: a cross-sectional study
JM Brown, M Siddiqui, DA Calhoun, RM Carey, PN Hopkins, GH Williams, ...
Annals of Internal Medicine 173 (1), 10-20, 2020
3772020
Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial
DF Kelly, DB Goodale, J Williams, DL Herr, ET Chappell, MJ Rosner, ...
Journal of neurosurgery 90 (6), 1042-1052, 1999
3181999
50th anniversary of aldosterone
JS Williams, GH Williams
The Journal of clinical endocrinology & metabolism 88 (6), 2364-2372, 2003
2512003
Impact of circadian disruption on cardiovascular function and disease
SL Chellappa, N Vujovic, JS Williams, FAJL Scheer
Trends in Endocrinology & Metabolism 30 (10), 767-779, 2019
2302019
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ...
The Lancet 397 (10293), 2476-2486, 2021
2212021
The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes
A Vaidya, JS Williams
Metabolism 61 (4), 450-458, 2012
2182012
Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway
OPR Hamnvik, TK Choueiri, A Turchin, RR McKay, L Goyal, M Davis, ...
Cancer 121 (2), 311-319, 2015
2162015
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia
JS Williams, GH Williams, A Raji, X Jeunemaitre, NJ Brown, PN Hopkins, ...
Journal of human hypertension 20 (2), 129-136, 2006
1422006
Six-month results of treatment-blinded medication titration for hypertension control after randomization to endovascular ultrasound renal denervation or a sham procedure in the …
M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, MD Lobo, ...
Circulation 139 (22), 2542-2553, 2019
1392019
Human resting energy expenditure varies with circadian phase
KM Zitting, N Vujovic, RK Yuan, CM Isherwood, JE Medina, W Wang, ...
Current Biology 28 (22), 3685-3690. e3, 2018
1352018
The independent association between 25‐hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS
A Vaidya, JS Williams, JP Forman
Obesity 20 (1), 186-191, 2012
1242012
25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians
A Vaidya, JP Forman, PN Hopkins, EW Seely, JS Williams
Journal of the Renin-Angiotensin-Aldosterone System 12 (3), 311-319, 2011
1212011
Relationship between aldosterone and progesterone in the human menstrual cycle
ED Szmuilowicz, GK Adler, JS Williams, DE Green, TM Yao, PN Hopkins, ...
The Journal of Clinical Endocrinology & Metabolism 91 (10), 3981-3987, 2006
1212006
Blood-pressure measurement
JS Williams, SM Brown, PR Conlin
N Engl J Med 360 (5), e6, 2009
109*2009
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter
RM Carey, CD Schoeffel, JJ Gildea, JE Jones, HE McGrath, LN Gordon, ...
Hypertension 60 (5), 1359-1366, 2012
1062012
The renin–angiotensin–aldosterone system and calcium-regulatory hormones
A Vaidya, JM Brown, JS Williams
Journal of human hypertension 29 (9), 515-521, 2015
1052015
Human interventions to characterize novel relationships between the renin–angiotensin–aldosterone system and parathyroid hormone
JM Brown, JS Williams, JM Luther, R Garg, AE Garza, LH Pojoga, ...
Hypertension 63 (2), 273-280, 2014
992014
Ala92 type 2 deiodinase allele increases risk for the development of hypertension
O Gumieniak, TS Perlstein, JS Williams, PN Hopkins, NJ Brown, BA Raby, ...
Hypertension 49 (3), 461-466, 2007
972007
The system can't perform the operation now. Try again later.
Articles 1–20